BRIDGEWATER, NEW JERSEY / ACCESS Newswire / June 17, 2025 / Tharimmune, Inc. (NASDAQ:THAR), a clinical-stage biotechnology company developing a portfolio of therapeutic candidates for inflammation and ...

Our great country generally believed to be on the last lap of journey through the wilderness to get to the promised land, ...

Tharimmune also announced that James Gordon Liddy (CDR US Navy SEAL (Ret)) has been appointed to its Board of Directors. Commander Liddy brings a distinguished career and unparalleled expertise in ...

BRIDGEWATER, NEW JERSEY / ACCESS Newswire / June 17, 2025 / Tharimmune, Inc. (NASDAQ:THAR), a clinical-stage biotechnology company developing a portfolio of therapeutic candidates for inflammation and ...